Nuclear power plants and childhood leukaemia: lessons from the past and future directions by Kuehni, Claudia E. & Spycher, Ben D.
Review article: Current opinion | Published 2 April 2014, doi:10.4414/smw.2014.13912
Cite this as: Swiss Med Wkly. 2014;144:w13912
Nuclear power plants and childhood leukaemia: lessons
from the past and future directions
Claudia E. Kuehni, Ben D. Spycher
Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
Summary
In the 1980s, leukaemia clusters were discovered around
nuclear fuel reprocessing plants in Sellafield and Dounreay
in the United Kingdom. This raised public concern about
the risk of childhood leukaemia near nuclear power plants
(NPPs). Since then, the topic has been well-studied, but
methodological limitations make results difficult to inter-
pret. Our review aims to: (1.) summarise current evidence
on the relationship between NPPs and risk of childhood
leukaemia, with a focus on the Swiss CANUPIS (Child-
hood cancer and nuclear power plants in Switzerland)
study; (2.) discuss the limitations of previous research; and
(3.) suggest directions for future research.
There are various reasons that previous studies produced
inconclusive results. These include: inadequate study
designs and limited statistical power due to the low preval-
ence of exposure (living near a NPP) and outcome (leuk-
aemia); lack of accurate exposure estimates; limited know-
ledge of the aetiology of childhood leukaemia, particularly
of vulnerable time windows and latent periods; use of res-
idential location at time of diagnosis only and lack of data
on address histories; and inability to adjust for potential
confounders.
We conclude that risk of childhood leukaemia around NPPs
should continue to be monitored and that study designs
should be improved and standardised. Data should be
pooled internationally to increase the statistical power.
More research needs to be done on other putative risk
factors for childhood cancer such as low-dose ionizing ra-
Abbreviations
ALL acute lymphoblastic leukaemia
CANUPIS study childhood cancer and nuclear power plants in
Switzerland
CI confidence interval
CL confidence limit
Geocap study childhood leukaemia around French nuclear power
plants
IRR incidence rate ratio
KIKK study German study of childhood cancer in the vicinity of
nuclear power plants
NPP nuclear power plant
OR odds ratio
SIR standardised incidence ratio
SMR standardised mortality ratio
diation, exposure to certain chemicals and exposure to in-
fections. Studies should be designed to allow examining
multiple exposures.
Key words: childhood; cancer; leukaemia; ionising
radiation; nuclear power plants; cancer registry
Introduction
In 1983, public attention was drawn to the possibility of
a link between nuclear installations and cancer after the
media reported on an excess of leukaemia among young
people in Seascale, a coastal village in north-west England
situated near the large nuclear fuel reprocessing site Sel-
lafield [1]. Since then, researchers in many countries have
investigated the risk of leukaemia and other cancers in chil-
dren living in the vicinity of nuclear power plants (NPPs)
[2–9], with mixed results. Taken as a whole, these studies
have found little evidence that living near a NPP increases
risk of childhood cancer, but a signal compatible with an
increased leukaemia risk was consistently evident for chil-
dren aged <5 years living <5 km to NPPs across several re-
cent studies [4–9].
It is established that moderate or high doses (above
100mSv) of ionising radiation increase the risk for child-
hood leukaemia [10]. Recent studies on natural background
radiation or radiation from medical examinations support
the claim that there is no “safe” threshold for ionising ra-
diation [11, 12]. For people who live in the vicinity of
NPPs, average yearly doses attributable to radioactive re-
leases from NPPs are magnitudes lower than those from
natural background radiation [1, 13–16]. Many scientists
thus believe that when risk of cancer coincides with prox-
imity to NPPs, it can be explained by confounding, i.e. oth-
er risk factors for leukaemia which are more common near
NPPs.
In this article, we summarise current evidence on the links
between residence near NPPs and risk of childhood leuk-
aemia, using as our main example the Swiss CANUPIS
(Childhood cancer and nuclear power plants in Switzer-
land) study. We included studies that we believe are im-
portant contributors to the current discussion; this is not a
systematic review of the literature. After the summary, we
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offer our opinions on the limitations of previous research
and suggest directions for future studies.
Childhood leukaemia: impact and
causes
Leukaemia is the most common childhood cancer, account-
ing for about 30% of cancer cases among children aged
0–14 years [17, 18]. In Switzerland and other industrialised
countries, about five new cases per 100,000 children occur
each year [18]. Incidence peaks at the age of 2–3 years
with eight to nine cases per 100,000 children annually [19,
20]. Among leukaemia subtypes, acute lymphoblastic leuk-
aemia (ALL) is the most common (80% of all children with
leukaemia) [18]. Childhood leukaemias fall into different
immunophenotypes and cytogenetic subtypes that vary in
prognosis, response to treatments and, possibly, in aeti-
ology [21, 22].
Little is known about the causes of childhood leukaemia.
Certain genetic syndromes such as neurofibromatosis and
Down’s syndrome increase the risk of leukaemia. Suscept-
ibility to childhood leukaemia is also affected by common
genetic variants [23].
Of the potential environmental causes, only ionising ra-
diation in moderate to high doses is a proven risk factor
for childhood leukaemia [10, 21, 24]. High-risk groups,
including survivors of the atomic bombings in Japan and
children receiving radiation therapy, provide sound evid-
ence for this [10]. Recent studies suggest that exposure to
low-dose ionising radiation from natural sources (cosmic
and terrestrial radiation, indoor radon) or from diagnostic
radiology increase the risk of childhood leukaemia in the
general population [10–12, 25]. Other possible environ-
mental risk factors include electromagnetic fields (ex-
tremely low frequency and radio frequency) [26], pesti-
cides and air pollution (particularly air pollution containing
carcinogenic compounds like benzene) [27–29]. However,
the results of studies that have investigated these environ-
mental factors are heterogeneous and inconclusive.
When investigating environmental factors, exposure his-
tory should be considered from conception to diagnosis,
because latency periods of leukaemia are insufficiently
known and characteristic chromosomal translocations for
leukaemia can occur already in utero [30, 31]. Furthermore,
as has been shown for ionising radiation [10], the first years
of life may be a critical time window during which children
are more susceptible to certain environmental exposures.
Results from some descriptive studies suggest that infec-
tions might play a role in the aetiology of childhood can-
cers, and particularly of ALL [21, 32, 33]. Observations in-
clude: a higher incidence of ALL in resource-rich countries
where early infections are less common than in resource-
poor countries [32]; a characteristic peak in the incidence
of ALL at age 2–4 years [20]; reports of local clusters in
which the number of diagnosed cases over short periods of
time was much greater than the number expected [34]; re-
ports of a general tendency for cases to cluster in space and
in space-time [35–37] and of seasonal patterns [38, 39]. As
yet, no molecular traces of specific viral agents have been
found in biological samples from patients with childhood
leukaemia [40, 41].
Available evidence on childhood
leukaemia risk and nuclear power
plants
Independent investigations commissioned by the British
government in the wake of the 1983 discovery confirmed a
markedly increased incidence near Sellafield [1] and Doun-
reay, another nuclear fuel reprocessing site in Scotland
[42], but concluded that these facilities released too little
radioactivity to explain the observed excess incidence.
Many studies on childhood cancer and nuclear installations
followed, in the UK and elsewhere. Most studies, sum-
marised in recent reviews [2, 4, 43, 44], were ecological.
Typically, they applied national cancer incidence rates to
the population of children that lived in given geographical
units (municipalities, communities or wards) and calcu-
lated the number of expected cancer cases in each unit.
Comparing observed to expected cancer cases returns the
standardised incidence ratio (SIR), an estimate of relative
risk of children living in an area, compared with the av-
erage risk country-wide. About 200 different nuclear fa-
cilities, including NPPs, research facilities, nuclear fuel or
weapons production sites and reprocessing plants in 10
countries, were investigated in this fashion [2]. Among
these, clear excesses were evident around only three sites:
the two nuclear reprocessing sites of Sellafield and Doun-
reay, and around Kruemmel, a power generating plant in
Germany [2]. There was no evidence of increased risk at
other sites, either singly or in aggregate [2]. A meta-analys-
is of 136 single sites did report slightly increased risks [43]
but its methodology was questionable [45].
Recent studies focused on young children (<5 years at dia-
gnosis) living very close (<5 km) to NPPs [4–8, 46–50].
Elevated leukaemia incidence around NPPs in this group
had first been found in a subgroup analysis of an ecological
study from Germany [51]. Public concern inspired repeated
investigation of this age-group in Germany [5, 48, 52]. The
most recent was a case-control study (German KiKK study:
study of childhood cancer in the vicinity of nuclear power
plants), [5, 48] that used exact distances between home ad-
dress at diagnosis and the nearest NPP to compare cancer
cases with population based controls. Odds ratios (ORs)
for leukaemia (OR 2.19, lower one-sided confidence limit
[CL] 1.51) and all cancers (OR 1.61, lower CL 1.26) were
significantly higher in this age-group [5, 48].
This study refuelled the debate among scientists, politicians
and the public. In its wake, the governments of surrounding
countries (Switzerland [6], the UK [4], France [7], Finland
[50] and Belgium [8]) commissioned studies to investigate
leukaemia incidence in under-fives living within 5 km of
NPPs. A French case-control study (Geocap: childhood
leukaemia around French nuclear power plants) found that
children <15 years old, who lived within 5 km of an NPP,
had a higher risk for acute leukaemia; for under-fives the
increase was not statistically significant (OR 1.6, 95% con-
fidence interval [CI] 0.7–4.1]) [7].
Table 1 compares the results of these studies for 0–4 year
olds. To make comparison easier, we give results from
ecological analyses (SIRs) for all countries. Results were
skewed in the same direction for most studies, except in
Finland, where no cases were observed within 5 km of a
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NPP. These studies suggest that leukaemia risk is slightly
increased in the 5 km zone, with SIRs ranging from 1.3 to
1.41.
Interpretation of findings
The large majority of previous studies did not confirm that
living near a NPP increases the risk of childhood leuk-
aemia. However, we cannot dismiss the possibility that
such an association does exist. First, clusters of leukaemia
cases have been observed around specific sites and, second,
results from studies of multiple sites suggest moderately el-
evated risks for under-fives who live very close to a NPP.
Different explanations for leukaemia clusters in the vicinity
of nuclear facilities have been proposed. The hypothesis
that leukaemia clusters are caused by radioactive releases
from these facilities is contradicted by studies showing that
such releases account for a small fraction of the overall
annual radiation dose, which comes mostly from natural
sources [2]. The hypothesis that changes in the germ cells
of fathers who worked in the facilities caused leukaemia in
their children has not been confirmed in independent stud-
ies [53]. Clusters might also be explained by the presence
of environmental pollutants other than ionising radiation,
such as chemicals, but no evidence for this has been found
[54].
A possible explanation for leukaemia clusters around nuc-
lear facilities is that rapid population influxes into previ-
ously isolated communities (population mixing) may lead
to localised epidemics of an as-yet unknown infection that
can cause leukaemia [55]. This hypothesis was originally
proposed as an explanation for the leukaemia cluster
around Sellafield, but might also explain leukaemia
clusters in other locations, apart from NPPs [56, 57]. A
series of studies have found elevated cancer risks following
historic events of intense population mixing, such as the
creation of new towns or large construction projects [58].
However, findings from studies using population growth
between two census time points or other census-based
measures of population mixing show less consistent results
[58–61].
Given our current knowledge, we cannot exclude the pos-
sibility that living in proximity to NPPs causes a moderate
increase in risk of childhood leukaemia. We suggest that
these open questions be addressed by more focused re-
search that avoids the limitations of previous studies. The
remainder of this article addresses this research and uses
the example of the CANUPIS study to show how some
challenges might be met.
The Swiss CANUPIS study
CANUPIS is a census-based cohort study that tested the
association between residence near one of the five Swiss
NPPs and increased risks of leukaemia and other childhood
cancers from 1985–2009 (study period) [6]. We used the
Swiss Childhood Cancer Registry to identify cancer cases
during this period and collected address histories from dia-
gnosis back to birth. For the census years 1990 and 2000,
we had access to precise geocoded places of residence for
the entire Swiss resident population and could use them to
calculate person years at risk for children of different age
and sex categories, in concentric zones around the NPPs
(<5 km, 5–10 km, 10–15 km, >15 km) (fig. 1). We per-
formed two analyses: a birth cohort analysis that included
children born in Switzerland during the study period; and,
a resident cohort analysis that included 0–15 year olds who
lived in Switzerland for any length of time during the study
period. We used addresses at birth and at diagnosis to com-
pare incidence of cancer in the three circles around NPPs
with incidence of cancer further away.
The birth cohort included 2,925 children with cancer, of
whom 953 (32.6%) had leukaemia. Compared with chil-
dren who were born >15 km away, the incidence rate ratios
(IRRs) for leukaemia in children born within 5 km of a
NPP were 1.20 (95% CI 0.60–2.41) for 0–4 year olds, and
1.05 95% CI 0.60–1.86) for 0–15 year olds; we found no
evidence of a relationship to distance. The resident co-
hort included 4,090 children with cancer of whom 1,345
(32.9%) had leukaemia. Corresponding IRRs were 1.41
(95% CI 0.78–2.55) for 0-4 year olds, and 1.24 (95% CI
Figure 1
Map showing consecutive 5-km zones (<5 km, 5–10 km, 10–15 km)
around the Mühleberg nuclear power plant, residential homes of
children from the general population (grey points), community
boundaries (grey faint lines, community “Wohlen bei Bern” with
green boundaries as an illustrative example).
Table 1: Leukaemia risk in 0–4 year old children living within 5 km of a nuclear power plant: ecological analyses from recent studies in five countries.
Study period Expected cases Observed cases SIR (95% CI)
Germany [5] 1980–2003 24.1 34 1.41 (0.98–1.97)
Finland [50] 1977–2004 NA 0 NA
United Kingdom* [4] 1969–2004 15.4 20 1.30 (0.79–2.01)
Switzerland [6] 1985–2009 7.9 11 1.40 (0.70–2.50)
France [7] 1990–2007 10.2** 14** 1.37 (0.75–2.30)
CI = confidence interval; NA = not available; SIR = standardised incidence ratio * Distance was calculated from centroid of administrative units (electoral wards in England
and Wales, postcode zones in Scotland) instead of from the child’s home. ** Includes only cases of acute leukaemia
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0.80–1.94) for 0–15 year olds. IRRs for all cancers were
similar to those for leukaemia. Results remained compar-
able when we included other nuclear facilities (research
and storage sites) and when we adjusted for potential con-
founders such as socioeconomic status, natural background
radiation, electromagnetic fields from radio and television
transmitters, distance to major roads, railway tracks, high-
voltage power lines and to land-use plots where heavy use
of agricultural pesticides was likely.
CANUPIS introduced several improvements over earlier
studies. It used nationwide routine datasets with high cov-
erage (census data and national cancer registry) and could
thus combine the advantages of ecological studies (large
samples, lack of selection bias) with those of case-control
studies (exact individual geocoding of residential ad-
dresses). The CANUPIS study adjusted for many potential
confounding factors, any of which could have affected es-
timates of the strength of association. The study used ad-
dress at birth as well as address at diagnosis, which allowed
us to account for exposures during prenatal and early post-
natal development. Because Switzerland is relatively small,
the study had limited statistical power. However, a com-
parison of total population levels between countries would
suggest lower statistical power than the study actually
achieved. Statistical power is largely determined by the
number of cases observed in the vicinity of NPPs, and
Swiss NPPs are situated in densely populated areas.
Challenges in research on nuclear
power plants and childhood leukaemia
In table 2, we summarise the main methodological chal-
lenges faced by researchers who explore links between
nuclear installations and leukaemia risk in children. We de-
scribe the main methodological problems and the resulting
consequences (columns 1 and 2), and summarise the ways
in which previous studies dealt with these issues (column
3).
Rarity of both outcomes and exposures
Childhood cancer is a rare disease and only few children
live in the immediate proximity of a NPP. This makes study
design challenging. Prospective cohort studies are infeas-
ible because of the exceedingly long wait times required to
observe a sufficient number of disease cases among a small
group of exposed individuals. Instead, earlier studies relied
on routine datasets (census and cancer registry or mortality
data) and ecological study designs. In such studies, prox-
imity to NPPs was typically measured from the centroid
of the community or county of residence, which did not
accurately capture the real distance between the child’s
home and the NPP. Large communities might stretch over a
wide distance range (illustrated in the example of Wohlen,
a Swiss community; see fig. 1). An observed association
between leukaemia risk and distance to NPPs at the com-
munity level may therefore not correctly reflect such an as-
sociation at an individual level (ecological fallacy). Fur-
thermore, ecological studies cannot adjust for confounders
at an individual level. Some studies could include inform-
ation on confounders at an aggregate level such as area-
based measures of socioeconomic status.
The rarity of outcomes and exposures also greatly affects
statistical power. Any given study includes only few ex-
posed cases. Previous studies attempted to increase stat-
istical power by enlarging the areas defined as exposed
(e.g. all communities with centroid within 20 km from a
NPP), by performing multi-site studies, or by maximising
the power of statistical tests [62].
Lack of accurate estimates of exposure to radiation
from NPP releases
Complex modelling is required to estimate the effective
doses that people receive when radionuclides are released
from NPPs (see [15, 63] for an overview). NPPs usually re-
lease trace amounts of radionuclides into the environment
and their dispersal and deposition depends on factors like
wind speed and direction and rainfall. Humans are exposed
through various routes that differ in their biological effects,
including inhalation (via air transport) or ingestion (via soil
deposition and food production), or through external irradi-
ation [63]. Even if doses are modelled for a given location,
the cumulative dose children receive will depend on their
residence history, possibly from preconception to the time
of diagnosis.
In earlier studies, exposure was usually approximated by
calculating distance between the centroid of the community
of residence and the NPP. More recent studies have used
exact distance measurements. Geocodes of residential ad-
dresses for the whole population are routinely available
only in Nordic countries and Switzerland, but these coun-
tries have small populations resulting in limited statistical
power [6, 50]. Studies from Germany [5] and France [7],
where exact addresses were available from cancer regis-
tries for leukaemia cases, but not for the whole population,
used case-control designs; they calculated precise distances
for cases and selected controls. Geocap used a representat-
ive sample of households from a central registry, and the
KiKK study obtained controls from registrar’s offices of in-
dividual communities. Because willingness to provide ad-
dresses was lower in communities near power plants, there
is concern that the KiKK study may have been affected
by selection bias. However, sensitivity analyses excluding
cases and controls from communities that did not fully co-
operate in selection of controls still found an increase risk
near NPPs, suggesting that results are not explained by se-
lection bias [64, 65].
Few studies have tried to improve measurements of expos-
ure. In an additional analysis, CANUPIS used prevailing
wind directions to investigate areas around NPPs in which
deposition of radionuclides was more likely, but found no
evidence of an association [6]. Geocap defined geograph-
ic zones based on distances and based on modelled doses
received by residents [66]. There was a statistically signi-
ficant association between leukaemia in preschool children
and distance to NPPs, but this was not evident in the dose-
based zoning.
Lack of knowledge on the aetiology of childhood
cancer
There is still much uncertainty regarding latency periods
or critical time windows of development of leukaemia, en-
vironmental risk factors other than ionising radiation, or
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about whether subtypes of leukaemia differ in their aeti-
ology. To our knowledge only CANUPIS and an earlier
ecological study [67] investigated exposure at birth. Other
studies focused only on exposure at the time of diagnosis
(incidence studies) or death (mortality studies). It is known
that certain chromosomal translocations characteristic of
leukaemia already occur in utero [31]. Aetiological mech-
anisms might also differ between subtypes of childhood
ALL [21]. Few studies have investigated subtype-specific
effects of environmental exposures, which might not show
up when subtypes are grouped.
Poor evidence on risk factors for childhood leukaemia also
limits our ability to explore relevant confounding factors.
In CANUPIS, the availability of precise geocodes allowed
us to estimate exposure to a number of potential con-
founders. None of these adjustments altered the results [6].
However, we ignored potential confounders that were more
difficult to assess and could not be estimated based on res-
idential location: individual data on socioeconomic status;
health behaviour (smoking, alcohol, exercise, etc.); use of
medicines and diagnostic and therapeutic radiation; expos-
ure to household chemicals. The German KiKK study as-
sessed a wide range of potential confounders in a nested
questionnaire survey, and found that correcting for these
did not markedly change results [48]. However, because re-
sponse rates to the questionnaire survey varied consider-
ably by distance to NPPs, particularly for controls, no firm
conclusions could be drawn regarding possible confound-
ing [48, 68].
Directions for future research on
nuclear power plants
The last column in table 2 summarises potential improve-
ments for future studies.
First, researchers should try to harmonise study designs.
Data assessed with comparable methods in different coun-
tries could then be pooled in an individual patient data
meta-analysis. This would improve statistical power and
reduce heterogeneity. Meta-analyses might then have
enough power to discern between leukaemia subtypes and
smaller age groupings, and consider different time-win-
dows of exposure.
At a minimum, we suggest a case control study design that
obtains cases from high coverage cancer registries and age
and sex matched controls from representative population
registers (register-based case controls study). Geocoded ad-
dresses of residence of all cases and controls should be
available so researchers can examine geographically de-
termined potential confounders or additional risk factors.
We also suggest exploring better methods for estimating
exposure. Estimations might be improved by straightfor-
ward extensions of geographic zoning, such as defining
zones of higher exposure according to prevalent wind dir-
ections, or spatial dose models like those used in Geocap.
Wherever possible, cumulative exposure via residence his-
tories should be obtained, back to conception. Where this
cannot be done, maternal address at child’s birth is as a
reasonable approximation of residence during pregnancy
and the first year of life.
Table 2: Methodological challenges of studies on childhood cancer and nuclear power plants and proposed solutions.
Problems Consequences Solutions in the past Proposed solutions for the future
1. Low prevalence of outcomes (childhood
cancer)
and exposure (proximity to NPPs)
Reduced statistical
power
Prospective cohort
studies not feasible
Reliance on routine
datasets and missing or
limited individual level
data on exposures and
confounders
Increased size of area defined as exposed (e.g.
all communities with centroid ≤20 km from NPP)
Multi-site studies
Designing tests of improved statistical power
[62]
Ecological studies using administrative area
units (e.g. county, community) and SIR (when
incidence data from cancer registries are
available) or SMR (using cause specific mortality
from mortality registries)
Standardised methodology and meta-
analyses of different studies (using
conventional or individual-patient data
meta-analyses)
Case control studies, preferably register-
based (to avoid the problem of selection
bias)
Census based cohort studies using
approximations for person-time at risk
(CANUPIS)
2. Difficulty of accurate exposure
measurement (This would require correct
modelling of transfer pathways of radioactive
releases and dosimetric modelling of effective
doses to humans [15, 63])
Reliance on proxy
measures such as
distance resulting in
misclassification of
individual exposure
Usually distance of centroid of geographic
unit or residence (e.g. county community) from
NPP
Use of precise distances between
residence and NPPs (German KIKK study
and CANUPIS)
Alternative functional relationships
between distance and cancer risk that
better reflect decline of radionuclide
concentrations with distance (German
KIKK study and CANUPIS)
Use of dose-based geographic zoning
(French Geocap study)
3. Lack of understanding of aetiology of
childhood leukaemia and childhood cancer
in general
Uncertainty regarding:
Latency and
developmental time
windows (pregnancy,
early childhood)
Potential variability
between leukaemia
subtypes
Relevant confounders
Usually, only place of residence at diagnosis
was studied
No adjustment for confounders, or ecological
adjustment for limited sets of confounders
Exposure during pregnancy and infancy
(residence at birth, CANUPIS)
Cumulative doses based on complete
address histories
Analysis of leukaemia subtypes
Individual adjustment for confounders
that can be estimated using place of
residence (CANUPIS)
Parallel investigation of “control sites”
that may have similar characteristics as
NPP sites (e.g. sites where NPPs were
planned but not built (CANUPIS) or
industrial areas)
NPP = nuclear power plant; SIR = standardised incidence ratio; SMR = standardised mortality rate
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A comparison of risk of leukaemia around NPP sites with
“control sites” selected for similarity to NPP sites could
correct for unknown risk factors common to NPP sites, but
unrelated to releases.
Conclusion
We must continue to monitor childhood cancer incidence in
the neighbourhood of NPPs and improve our methodology.
Future studies should collect detailed information on mul-
tiple exposures and their datasets should be designed to an-
swer more than one research question. Setting an interna-
tional standard of minimum methodological requirements
will facilitate pooled analyses. These measures should al-
low channelling scarce financial resources into more ef-
fective research on the causes of childhood leukaemia.
Research on leukaemia risk near NPPs need not have the
highest priority: the argument for harmful effects of NPPs
in normal operation has little plausibility. As noted previ-
ously, it makes little sense to test a hypothesis if it is a pri-
ori considered to be unreasonable [69]. This research will
also grow less pressing if countries move away from nuc-
lear energy and toward alternative sources, as is the case in
Switzerland. But as long as NPPs remain in use, arguments
against a link between radioactive releases during normal
operation and childhood cancer must be weighed against
the concerns of the population and policy makers. Regard-
less of whether or not such a link exists, a distrust of nucle-
ar power stemming from the fear of catastrophic events is
likely to remain.
We suggest that resources would be best focused on basic
research into the aetiology of childhood cancer, including
critical developmental processes and the temporal aspects
of disease initiation and progression, and on versatile epi-
demiological studies that can address various hypothesised
disease causes in parallel.
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Figures (large format)
Figure 1
Map showing consecutive 5-km zones (<5 km, 5–10 km, 10–15 km) around the Mühleberg nuclear power plant, residential homes of children
from the general population (grey points), community boundaries (grey faint lines, community “Wohlen bei Bern” with green boundaries as an
illustrative example).
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